Biotechnology Firm ImmuneWorks Supports Pulmonary Fibrosis Week by Increasing National Recruitment Efforts to Enroll Idiopathic Pulmonary Fibrosis (IPF) Patients in Clinical Trial
9/19/2011 8:46:21 AM
More...
|
Biotechnology Firm ImmuneWorks Begins National Clinical Trial for New Idiopathic Pulmonary Fibrosis (IPF) Treatment
10/19/2010 11:26:53 AM
More...
|
LungRx Inc. (UTHR) and ImmuneWorks Announce Collaboration in Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction
2/10/2010 8:49:11 AM
More...
|